These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3086113)

  • 1. Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse and rabbit.
    Muller LA; Añasco N; González Cappa SM
    Exp Parasitol; 1986 Jun; 61(3):284-93. PubMed ID: 3086113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages.
    Lages-Silva E; Ramirez LE; Krettli AU; Brener Z
    Parasite Immunol; 1987 Jan; 9(1):21-30. PubMed ID: 3104865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on epimastigote and metacyclic stages of Trypanosoma cruzi. II. Selective lysis by rodent sera.
    Chao D; Hsu YP; Chan CH; Chen YA
    Int J Zoonoses; 1985 Dec; 12(4):323-30. PubMed ID: 3939135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
    Umekita LF; Ramos DP; Barbaro KC; Mota I
    Immunol Lett; 1999 Nov; 70(2):73-6. PubMed ID: 10569694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.
    Yoshida N
    Exp Parasitol; 1986 Apr; 61(2):184-91. PubMed ID: 3082663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.
    Norris KA; Harth G; So M
    Infect Immun; 1989 Aug; 57(8):2372-7. PubMed ID: 2663722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct agglutination test in the detection of anti-Trypanosoma cruzi antibodies in mice.
    Schmunis GA; Szarfman A; Vattuone N
    J Parasitol; 1972 Oct; 58(5):1006-7. PubMed ID: 4627886
    [No Abstract]   [Full Text] [Related]  

  • 9. Isotype of antibodies responsible for immune lysis in Trypanosoma cruzi infected mice.
    Stefani MM; Takehara HA; Mota I
    Immunol Lett; 1983; 7(2):91-7. PubMed ID: 6418640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of insect-borne, metacyclic forms of Trypanosoma cruzi to antibody-mediated mechanisms of destruction.
    Kierszenbaum F; Lima MF
    Am J Trop Med Hyg; 1983 Nov; 32(6):1236-41. PubMed ID: 6418013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
    Wendelken JL; Rowland EC
    J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection.
    Heath AW; Martins MS; Hudson L
    Trop Med Parasitol; 1990 Dec; 41(4):425-8. PubMed ID: 2127473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection.
    Marques T; Silva GC; Henrique Paiva PM; Nascentes GAN; Ramirez LE; Norris K; Meira WSF
    Exp Parasitol; 2018 Jan; 184():103-108. PubMed ID: 29246832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
    Plata F; Wietzerbin J; Pons FG; Falcoff E; Eisen H
    Eur J Immunol; 1984 Oct; 14(10):930-5. PubMed ID: 6208038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
    BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against Trypanosoma cruzi in mice infected with T. rangeli.
    Guhl F; Marinkelle CJ
    Ann Trop Med Parasitol; 1982 Jun; 76(3):361. PubMed ID: 6812517
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
    Milani SR; Travassos LR
    Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptides.
    Zweerink HJ; Weston HD; Andersen OF; Garber SS; Hayes EC
    Infect Immun; 1984 Dec; 46(3):826-30. PubMed ID: 6437990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of metacyclic trypomastigotes of Trypanosoma cruzi and Trypanosoma dionisii from culture using an epimastigote-specific monoclonal antibody.
    Petry K; Schottelius J; Baltz T
    Parasitol Res; 1987; 73(3):224-7. PubMed ID: 3295861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.